Prodrugs of 2’,3’-Didehydro-3’-deoxythymidine (D4T): Synthesis, Antiviral Activity, and Rapid Pharmacokinetic Evaluation
- 1 March 1994
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 83 (3) , 339-343
- https://doi.org/10.1002/jps.2600830315
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-DideoxyinosineScience, 1989
- Glucuronidation of 3'-azido-3'-deoxythymidine: Human and rat enzyme specificityBiochemical Pharmacology, 1989
- Comparative pharmacokinetics of new anti-HIV agents: 2', 3'-dideoxyadenosine and 2', 3'-dideoxyinosineBiochemical Pharmacology, 1989
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Potent and selective anti-HTLV-IIILAV activity of 2′,3′-dideoxycytidinene, the 2′,3′-unsaturated derivative of 2′,3′-dideoxycytidineBiochemical and Biophysical Research Communications, 1986
- Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.Proceedings of the National Academy of Sciences, 1986
- Human T-Cell Leukemia Viruses (HTLV): A Unique Family of Pathogenic RetrovirusesAnnual Review of Immunology, 1985
- A Pathogenic Retrovirus (HTLV-III) Linked to AIDSNew England Journal of Medicine, 1984
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983